Abstract
The design, synthesis, thermodynamic and crystallographic characterization of a potent, broad spectrum, second-generation HIV-1 entry inhibitor that engages conserved carbonyl hydrogen bonds within gp120 has been achieved. The optimized antagonist exhibits a submicromolar binding affinity (110 nM) and inhibits viral entry of clade B and C viruses (IC50 geometric mean titer of 1.7 and 14.0 μM, respectively), without promoting CD4-independent viral entry. The thermodynamic signatures indicate a binding preference for the (R,R)- over the (S,S)-enantiomer. The crystal structure of the small-molecule/gp120 complex reveals the displacement of crystallographic water and the formation of a hydrogen bond with a backbone carbonyl of the bridging sheet. Thus, structure-based design and synthesis targeting the highly conserved and structurally characterized CD4-gp120 interface is an effective tactic to enhance the neutralization potency of small-molecule HIV-1 entry inhibitors.
Original language | English (US) |
---|---|
Pages (from-to) | 338-343 |
Number of pages | 6 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 4 |
Issue number | 3 |
DOIs | |
State | Published - Mar 14 2013 |
Keywords
- CD4
- HIV
- X-ray crystallography
- entry inhibitor
- gp120
- protein-protein interactions
- structure-based drug design
- thermodynamics
- viral inhibition
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry